Release Date: 21/07/09 13:51 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 978.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%